Cargando…
Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301619/ https://www.ncbi.nlm.nih.gov/pubmed/34297782 http://dx.doi.org/10.1371/journal.pone.0255429 |
Ejemplares similares
-
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
por: Chen, Dung-Tsa, et al.
Publicado: (2021) -
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
Publicado: (2014) -
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2020) -
Correction: Heterogeneity of endometriosis lesions requires individualisation of diagnosis and treatment and a different approach to research and evidence based medicine
por: Koninckx, PR, et al.
Publicado: (2020) -
Correction: Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients
por: Wang, Hongmei, et al.
Publicado: (2022)